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a PATTERNS & PHENOTYPES
Differential Expression and Regulation by
Activin of the Neurotrophins BDNF and
NT4 During Human and Mouse Ovarian
Development
Andrew J. Childs,1* Rosemary A.L. Bayne,1 Alison A. Murray,2 Sarah J. Martins Da Silva,1
Craig S. Collins,1 Norah Spears,2 and Richard A. Anderson3
The tropomyosin-related kinase (Trk) B neurotrophin receptor is essential for ovarian germ cell survival
and primordial follicle formation, but the contributions of its ligands, brain-derived neurotrophic factor
(BDNF) and neurotrophin-4 (NT4), are unknown. We have investigated their expression and regulation in
developing human and mouse ovaries. BDNF expression increased with increasing gestation, expression
of human NTF4 and of both Ntf5 and Bdnf in the mouse was unchanged. Bdnf expression was dramati-
cally lower than Ntf5 in the mouse, but levels were comparable in the human. Human fetal ovarian so-
matic cells expressed BDNF. Activin A selectively regulated BDNF and Ntf5 expression in human
and mouse, respectively, identifying an oocyte/somatic signaling pathway which might mediate the pro-
survival effects of activin. These data reveal that expression and regulation of the TrkB ligands
are differentially controlled in the developing ovaries of humans and mice, and identify BDNF as a
potential regulator of germ cell fate in the human fetal ovary. Developmental Dynamics 239:1211–1219,
2010. VC 2010 Wiley-Liss, Inc.
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INTRODUCTION
The early development of the mamma-
lian ovary is characterized by sequen-
tial waves of mitotic germ cell prolifer-
ation, meiotic entry and arrest, and
subsequent association of oocytes with
somatic cells to form primordial
follicles. Extensive germ cell death
occurs throughout these periods
(Baker, 1963; Pepling and Spradling,
2001), and assembly of oocytes into
primordial follicles is necessary for
their continued survival (Hirshﬁeld,
1991; Fulton et al., 2005). The molecu-
lar mechanisms regulating these proc-
esses remain largely unknown, but the
targeted disruption of several signal-
ing pathways in rodent models has
revealed extensive and bi-directional
intercellular communication between
the somatic and germ cell compart-
ments to be crucial in controlling the
onset and extent of follicle formation
(reviewed in Skinner, 2005; Tingen
et al., 2009).
Among the signaling pathways
implicated in regulating oogenesis and
follicle formation in the developing
ovary, the neurotrophin signaling sys-
tem appears to be of particular impor-
tance (Ojeda et al., 2000; Dissen et al.,
2002, 2009). The neurotrophins are a
family of peptide growth factors which
D
ev
el
op
m
en
ta
l D
yn
am
ic
s
1MRC Human Reproductive Sciences Unit, Centre for Reproductive Biology, The Queen’s Medical Research Institute, Edinburgh, United
Kingdom
2Centre for Integrative Physiology, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, United Kingdom
3Division of Reproductive and Developmental Sciences, University of Edinburgh, Centre for Reproductive Biology, The Queen’s Medical
Research Institute, Edinburgh, United Kingdom
Grant sponsor: Medical Research Council; Grant numbers: WBS U.1276.00.002.00001, G0400868.
*Correspondence to: Andrew J. Childs, MRC Human Reproductive Sciences Unit, Centre for Reproductive Biology, The
Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. E-mail: a.childs@hrsu.mrc.ac.uk
DOI 10.1002/dvdy.22252
Published online 19 February 2010 in Wiley InterScience (www.interscience.wiley.com).
DEVELOPMENTAL DYNAMICS 239:1211–1219, 2010
VC 2010 Wiley-Liss, Inc.
signal through ligand-speciﬁc tropo-
myosin-related kinase (Trk) receptors
and the common p75NTR receptor
(Bibel and Barde, 2000). Within the
nervous system, neurotrophins have
diverse roles in regulating neuronal
survival, proliferation, differentiation
and migration in a cell type- and
context-speciﬁc manner (Davies, 2000;
Bernd, 2008). The expression of com-
ponents of the neurotrophin signaling
pathway is not restricted to neural tis-
sues, however, indicating the exis-
tence of functional roles for neurotro-
phins in other organ systems
(Tessarollo, 1998). Much of the neuro-
trophin signaling apparatus is
expressed within the developing
rodent and human ovary and testis,
with several components displaying
developmentally regulated expression
changes around the time of primordial
follicle formation (Dissen et al., 1995;
Anderson et al., 2002; Robinson et al.,
2003; Paredes et al., 2004; Dissen
et al., 2009).
Signaling through the TrkB neuro-
ptrophin receptor is essential for nor-
mal ovarian development, as targeted
disruption of Ntrk2 (encoding the
TrkB receptor) results in a phenotype
of impaired ovarian germ cell survival,
reduced primordial follicle numbers
(Spears et al., 2003; Kerr et al., 2009)
and arrest of developing follicles at the
primary to secondary follicle stage
(Paredes et al., 2004). Expression of
the TrkB receptor is restricted to germ
cells in the feto-neonatal ovaries of
humans and rodents at comparable
developmental stages (Dissen et al.,
1995; Anderson et al., 2002; Spears
et al., 2003; Paredes et al., 2004), and
is detectable in increasing amounts in
germ cells in the fetal mouse ovary in
the days before birth and the onset of
follicle formation (Spears et al., 2003).
TrkB binds two major neurotrophic
ligands, namely brain-derived neuro-
trophic factor (BDNF, encoded by the
Bdnf gene) and neurotrophin-4 (NT4,
the product of the Ntf5 locus in
rodents, and the NTF4 gene in
humans). Whereas the expression of
transcripts encoding both of these fac-
tors has been reported in the feto-neo-
natal ovaries of both humans and
mice, the relative levels of each have
not been established, nor have devel-
opmental changes been investigated.
Furthermore, whereas NT4 expres-
sion has been localized to the somatic
cells of the developing human fetal
ovary (Anderson et al., 2002), the dis-
tribution of BDNF expression within
the human fetal ovary remains
unknown.
The biological signiﬁcance of the
expression of both BDNF and NT4 in
the developing ovary is unclear, but
may indicate neurotrophin-mediated
regulation of more than one aspect of
ovarian development at the time of fol-
licle formation. Differential effects of
BDNF and NT4 on neuronal survival
and synapse formation have been
reported, despite both ligands acting
through the same (TrkB) receptor
(Conover et al., 1995; Minichiello
et al., 1998; Fan et al., 2000; Kalb,
2005). Given the essential role of TrkB
in primordial follicle formation in the
mouse and evidence for a similar func-
tion in the human, we have investi-
gated the expression and regulation of
its ligands BDNF and NT4 in the
period leading up to and during pri-
mordial follicle formation. We report
here on a detailed analysis of develop-
mental changes in expression of these
growth/survival factors in the develop-
ing human and mouse ovary. Further-
more, in light of evidence that germ
cell-expressed activin A indirectly pro-
motes the proliferation and survival of
germ cells in the human fetal ovary by
inﬂuencing neighboring somatic cells
(Martins da Silva et al., 2004; Coutts
et al., 2008; Childs and Anderson,
2009), we have also investigated
whether BDNF and NT4 may be can-
didates for activin-regulated somatic
cell-derived modulators of germ cell
survival in the developing human and
mouse ovary.
RESULTS AND DISCUSSION
TrkB Ligands Are
Differentially Expressed in
the Developing Ovaries of
Humans and Mice
To establish the relative roles of TrkB
ligands in oogenesis and follicle forma-
tion in the developing ovary, we ﬁrst
determined the expression proﬁles of
transcripts encoding BDNF and NT4
in human and mouse ovaries at com-
parable developmental stages, from
the initiation of meiosis to the onset of
follicle formation. Both genes were
expressed throughout this period in
the human fetal ovary and standardi-
zation to the expression of the house-
keeping gene glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH)
allowed comparison of relative expres-
sion between BDNF and NTF4. This
revealed similar levels of expression of
BDNF and NTF4 at all gestations
examined (Fig. 1A), although we
detected differences in the expression
of the two genes over the developmen-
tal window investigated. The expres-
sion of BDNF increased concomitant
with the onset of primordial follicle
formation in the human fetal ovary
with levels of transcripts encoding
BDNF signiﬁcantly higher at 19weeks
gestation (2.27 6 0.55 pmol BDNF
transcript/nmol GAPDH transcript)
than at 14 or 15 weeks (0.80 6 0.22
pmol/nmol and 0.99 6 0.10 pmol/nmol
GAPDH, respectively, n ¼ 5–6 per ges-
tational group, P ¼ 0.03), an approxi-
mately 2.5-fold increase over the ges-
tational range examined. In contrast,
expression of NTF4 increased 1.6-
fold over the gestational range exam-
ined, but this change was not statisti-
cally signiﬁcant. It appears therefore
that the expression of BDNF, but not
that ofNTF4, is developmentally regu-
lated across mid-gestation in the
human fetal ovary with an increase at
the time primordial follicles are ﬁrst
seen.
In direct contrast to situation in the
human, we found expression ofNtf5 to
be substantially higher than that of
Bdnf in the mouse ovary across a com-
parable window in development (from
embryonic day [E] 14.5 to postnatal
day [P] 2), with the levels of tran-
scripts encoding BDNF approximately
200 times lower than those encod-
ing NT4 at P2. Expression of Ntf5
appeared to increase gradually
between E14.5 and P2, although this
change did not reach statistical signiﬁ-
cance (26.0 6 5.8 pmol/nmol rising to
89.66 46.9 pmol/nmolGapdh; P¼ 0.5;
Fig. 1B), and no discernable change
was observed in the expression ofBdnf
over the gestational range examined.
Notably, we failed to detect an increase
in Ntf5 expression around the time of
follicle formation comparable to that
reported previously in the neonatal
rat ovary immediately after birth (Dis-
sen et al., 1995). In the developing
mouse ovary therefore, Ntf5 appears
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to be the predominantly expressed
TrkB ligand, whereas in the human
both ligands are expressed at similar
levels but only BDNF is developmen-
tally regulated.
The ﬁnding that Ntf5 expression is
substantially higher than that of
Bdnf in the mouse feto-neonatal
ovary (up to 200 at P2) is consist-
ent with the original description of
high NT4 and low BDNF expression
in Xenopus ovary, in contrast to all
other tissues (Hallbook et al., 1991).
This is striking given that expression
from a single endogenous Bdnf allele
is sufﬁcient to maintain normal fertil-
ity in Ntf5/,Bdnfþ/ mice (Liu et al.,
1995; although whether Bdnf expres-
sion from the only remaining allele is
up-regulated to compensate has not
been determined). Such differences in
the expression of the two TrkB
ligands may reﬂect a physiological
requirement to balance the levels of
the two ligands relative to each other
within the developing ovary. Indeed, a
possible context-dependent dosage
effect of TrkB ligands has been
reported in mice in which the coding
sequence for NT4 has been knocked
into the Bdnf locus (Bdnfnt4ki; Fan
et al., 2000). Whereas mice carrying
one knock-in allele and one null allele
(Bdnfnt4ki/) are normal and fertile,
those that are homozygous for the
knock-in allele (Bdnfnt4ki/nt4ki) are
mostly infertile. This suggests that,
although a small excess of NT4 in the
absence of BDNF is tolerated, the pro-
duction of NT4 from both Bdnf loci
has a detrimental effect on fertility
(Fan et al., 2000). Whether this phe-
notype arises in part from the two
neurotrophins exerting differing bio-
logical potencies, as occurs in other
organ systems (Minichiello et al.,
1998; Kalb, 2005), remains to be
determined, however.
The absence of any change in the
expression of both NTF4 in the
human, and Ntf5 in the mouse across
the period examined suggests that
NT4 may not be a key regulator of fol-
licle formation in either species; a hy-
pothesis supported by the absence of a
subfertility phenotype in homozygous
NT4-deﬁcient mice (Conover et al.,
1995). This result differs from expres-
sion of transcripts encoding NT4 in the
neonatal rat ovary, which have been
reported to increase sharply but tran-
siently in the hours after birth (Dissen
et al., 1995). Only the expression of
BDNF in the human fetal ovary
appeared to be developmentally regu-
lated across the gestational range
examined, with expression being sig-
niﬁcantly higher at 19 weeks gestation
than at 14 and 15 weeks. This increase
in BDNF therefore correlates with the
onset of primordial follicle formation
in the human (18 weeks gestation).
The small (two-fold) increase in
BDNF expression with gestation
reported here is likely to be below the
sensitivity of recent whole-genome
microarray studies investigating gene
Fig. 1. Expression of the genes encoding brain-derived neurotrophic factor (BDNF) and neuro-
trophin-4 (NT4) in the developing human and mouse ovary. A: Expression of BDNF and NTF4 in
the human fetal ovary. Expression of BDNF increased with gestation, and was significantly
higher around the time of primordial follicle formation than at early gestations (a vs. b; P <
0.03). In contrast to the mouse, BDNF expression was comparable to that of NTF4. Expression
of NTF4 did not change significantly over gestation. B: Expression of Bdnf and Ntf5 in the
mouse feto-neonatal ovary from the onset of meiosis (embryonic day [E] 14.5) to primordial fol-
licle formation (postnatal day [P] 2). Ntf5 transcript levels rose slightly with increasing gestation,
peaking around the onset of primordial follicle formation, but this was not significant. Bdnf levels
were consistently very low at all gestations examined and showed no change over the period
examined.
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expression in the human fetal ovary
around the time of primordial follicle
formation (Fowler et al., 2009; Hou-
mard et al., 2009), validating our
quantitative reverse transcriptase-po-
lymerase chain reaction (qRT-PCR) -
based approach for detecting small
changes in the expression of candidate
genes relevant to this process.
BDNF Is Predominantly
Expressed by the Somatic
Cells of the Human Fetal
Ovary
The distribution of NT4 protein in the
human fetal ovary has been reported
previously (Anderson et al., 2002);
however, no comparable data exist on
the expression of BDNF. We therefore
performed immunohistochemistry to
identify the site(s) of BDNF produc-
tion in the developing human fetal
ovary. BDNF was localized to the cyto-
plasm of somatic cells of the fetal ovary
in all specimens/gestations examined,
from 9 to 20 weeks gestational age
(Fig. 2A–F). The distribution of BDNF
Fig. 2. Immunohistochemical localization of brain-derived neurotrophic factor (BDNF) in the developing human fetal ovary. BDNF expression was
detected at all stages examined. A: Expression of BDNF (brown staining) in somatic cells (sc) surrounding primordial germ cells (gc) in a first tri-
mester (60 days gestation) human fetal ovary. B,C: At 14 (B) weeks and 20 weeks (C); BDNF is predominantly expressed in a corticomedullary
gradient, with weak expression in somatic cells near the ovarian periphery, and intense expression in those interspersed between larger germ cells
away from the periphery. C, inset: BDNF expression is detectable in the pregranulosa cells of primordial follicles (pf), and in some large germ cells
(closed arrows), whereas others of comparable size and show no expression (open arrows). D: At 20 weeks; BDNF immunopositive germ cells are
detectable within primordial follicles. E: At 18 weeks; BDNF expression varies between germ cells within the same nest, with immunopositive and
immunonegative germ cells in existing close proximity. F: At 18 weeks; BDNF expression is strongest in somatic cells interspersed within germ
cell nests and in primordial follicles. No expression is detectable in somatic cells within cell streams (cs). F, inset: negative control, primary anti-
body preincubated with immunizing peptide. Scale bars ¼ 500 mm in A–D, 100 mm in E,F).
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within the ovary was found to be non-
homogeneous, however, with weaker
expression detected in somatic cells
associated with less mature germ cells
at the periphery of the ovary, andmore
intense staining in somatic cells asso-
ciated with larger, more mature germ
cells toward the more central region of
the organ in the second trimester (Fig.
2B,C). This was clearest at later gesta-
tions, after the onset of primordial fol-
licle formation (Fig. 2C). Strong
expression was detected in somatic
cells interspersed within nests of germ
cells, and in the pregranulosa cells of
primordial follicles, but BDNF expres-
sion was very low/absent in somatic
cells in streams between clusters (Fig.
2D,F). At later gestations, expression
of BDNF could also be detected in the
cytoplasm of some larger germ cells
including those within newly formed
primordial follicles (Fig. 2D,E)
although variation in BDNF expres-
sion was apparent between adjacent
germ cells within the same nest (Fig.
2E,F).
The pattern of BDNF protein ex-
pression in the somatic cells of the
human fetal ovary is similar to that we
have reported previously for NT4
(Anderson et al., 2002). The produc-
tion of both NT4 and BDNF by somatic
cells, and the expression of TrkB
receptors by germ cells in the develop-
ing ovary, strongly suggests a role for
somatic cell-derived TrkB ligands in
regulating oocyte development. The
expression of BDNF by germ cells at
later gestations reveals additional lev-
els of complexity in TrkB signaling in
the human fetal ovary, indicating that
germ cell fate may be regulated by
both paracrine and autocrine neuro-
trophin signaling. Furthermore, the
onset of BDNF expression in germ
cells at this stage may explain part of
the apparent increase in BDNF
mRNA levels around the time of fol-
licle formation detailed above.
In contrast to the situation in the
human fetal ovary, we were unable to
detect any expression of Bdnf protein
in the developing mouse ovary by
immunohistochemistry, although ro-
bust Bdnf expression was detectable
in mouse brain as a positive control
(data not shown). This result conﬁrms
the suggestion from our qRT-PCR data
detailed above that Bdnf is expressed
at an extremely low level, if at all, in
the feto-neonatal mouse ovary.
Activin A Selectively
Regulates Expression of
BDNF in the Human and
Ntf5 in the Mouse Ovary
The Transforming Growth Factor-b
(TGF-b) superfamily member activin
A is transiently expressed by oocytes
in syncitial clusters, and is a central
regulator of germ cell survival and pri-
mordial follicle formation in the feto-
neonatal ovaries of both humans and
rodents (Martins da Silva et al., 2004;
Bristol-Gould et al., 2006). Activin
inﬂuences germ cell behavior indi-
rectly, by regulating the expression of
reciprocal signals produced by neigh-
boring somatic cells (Coutts et al.,
2008; Childs and Anderson, 2009),
however, the identity of the factors
produced by somatic cells that inﬂu-
ence oocyte proliferation and survival
in response to activin remain largely
unknown. Given the localization of
BDNF (this study) and NT4 (Anderson
et al., 2002) to somatic cells inter-
spersed between oocytes in germ cell
nests, we postulated that these factors
may represent good candidate factors
for activin-regulated somatic cell-to-
oocyte signalingmolecules. To test this
hypothesis, we performed cultures of
disaggregated second trimester
human fetal ovaries (14–17 weeks ges-
tational age) in the presence or ab-
sence of recombinant human activin A
for 18–24 hr and determined the
expression of BDNF and NTF4 by
quantitative RT-PCR. These experi-
ments demonstrated that activin A
increased BDNF expression ﬁve-fold
relative to untreated controls (5.2 6
0.7; P ¼ 0.02; n ¼ 5), but had no effect
on the expression of NTF4 (1.01 6
0.09, not signiﬁcant, Fig. 3).
To determine whether the regula-
tion of neurotrophin expression by
activin is conserved between mouse
and human, we cultured somatic cells
from neonatal mouse ovary in the
presence or absence of recombinant
activin A, and assessed the effects on
the expression ofBdnf andNtf5. Treat-
ment of somatic cells with recombi-
nant activin for ﬁve days resulted in a
Fig. 3. Selective regulation of tropomyosin-related kinase (Trk) B ligand expression by Activin A
in cultures of human fetal ovary and mouse neonatal ovarian somatic cells. Treatment of disag-
gregated second trimester human fetal ovaries (14–17 weeks gestational age, n ¼ 5) with
recombinant human activin A increased brain-derived neurotrophic factor (BDNF) expression
five-fold relative to untreated controls (5.2 6 0.7; P ¼ 0.02), but had no effect on the expression
of NTF4 (1.01 6 0.09, not significant). Comparable treatments of newborn mouse granulosa
cells with activin for 5 days resulted in a six-fold (6.1 6 1.05; P ¼ 0.01; n ¼ 4) increase in Ntf5
gene expression. Bdnf transcript levels were too low to be reliably determined both in controls
and after activin treatment.
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six-fold (6.1 6 1.05; P ¼ 0.01; n ¼ 4)
increase in Ntf5 gene expression
(Fig. 3), whereas Bdnf transcript lev-
els remained below the threshold
required for reliable detection.
Although the speciﬁc TrkB ligand-
encoding gene that is regulated by
activin A appears to have diverged
between humans and mice, it is nota-
ble that activin regulates the more
highly expressed (Ntf5 in mouse) or
more regulated (BDNF in human) of
the two TrkB neurotrophin genes sug-
gesting that the relative physiological
importance of the two ligands within
the ovaries of humans and rodents
may have been reversed. The ﬁnding
that these two genes (BDNF in the
human and Ntf5 in the mouse) encod-
ing signaling molecules with estab-
lished roles in the regulation of germ
cell survival and proliferation are
downstream transcriptional targets of
oocyte-derived activin signaling, sup-
ports our hypothesis that activin A
acts to promote the expression of recip-
rocal signals that inﬂuence germ cell
survival, and repress those which en-
courage oocyte maturation and follicle
formation. Indeed, we have recently
identiﬁed kit ligand as a another
potential target of activin action in the
human fetal ovary (Coutts et al., 2008;
Childs and Anderson, 2009), and it is
likely that other such factors remain
to be identiﬁed.
Conclusions
Bi-directional communication bet-
ween the germ and somatic cell com-
partments of the ovary is essential in
the regulation of germ cell prolifera-
tion and survival, in orchestrating the
breakdown of germ cell nests, and in
the subsequent association of oocytes
with pregranulosa cells that leads to
the formation of primordial follicles.
In support of recent data highlighting
the importance of TrkB signaling in
establishing the primordial follicle
pool in mice (Spears et al., 2003; Kerr
et al., 2009), the data presented here
reveal differential expression of the
TrkB ligands NT4 and BDNF, and
species-speciﬁc differences between
humans and mice in the regulation of
TrkB ligand gene expression by acti-
vin A.
What then is the role of TrkB ligand
signaling onto germ cells in the fetal
ovary? The downstream targets of
BDNF and NT4 action in the develop-
ing ovary are yet to be conclusively
identiﬁed, although an increasing
body of evidence suggests a role for
these factors in preventing germ cell
death. Pharmacological inhibition of
all Trk receptor signaling with the in-
hibitor K252a impairs germ cell sur-
vival in both the human fetal ovary
(Spears et al., 2003) and testis (Robin-
son et al., 2003). Mice carrying tar-
geted disruptions of the Ntrk2 (TrkB)
locus display defects in germ cell sur-
vival and follicle formation and devel-
opment (Spears et al., 2003; Kerr
et al., 2009). Furthermore, the ﬁnding
that both NT4 and BDNF can prevent
apoptosis in human embryonic stem
cells (Pyle et al., 2006), a cell type
suggested to share many phenotypic
similarities with early germ cells
(Zwaka and Thomson, 2005), adds
weight to the hypothesis that TrkB
ligands may be involved in regulating
germ cell death. Indeed, given the
onset of BDNF expression in the larg-
est germ cells around the time of nest
breakdown, and the variation in
BDNF expression between germ cells
within the same nest (Fig. 2C,F), it is
tempting to speculate that BDNF/
TrkB signaling may be involved in
determining which germ cells are
subject to the selective apoptosis that
triggers germ cell nest breakdown
leading to primordial follicle forma-
tion (Pepling and Spradling, 2001).
Work from our laboratory and others
has demonstrated that activin A
exerts both pro-proliferation and pro-
survival effects on germ cells in the
developing mammalian ovary (Mar-
tins da Silva et al., 2004; Bristol-
Gould et al., 2006), and that these
effects are mediated indirectly by
modulating the expression of growth
factors produced by neighboring so-
matic cells (Coutts et al., 2008; Childs
and Anderson, 2009). The ﬁnding that
the expression of the genes encoding
BDNF (in the human) and NT4 (in
the mouse) are regulated by activin,
suggests these factors may be down-
stream effectors of the positive effects
of activin on germ cell development. A
recent report has suggested that
expression of components of the notch
signaling pathway may be dysregu-
lated in the ovaries of TrkB-null mice
(Kerr et al., 2009). Given that notch-
jagged signaling has recently been
demonstrated to regulate the timing
and extent of primordial follicle for-
mation in the mouse (Trombly et al.,
2009), this observation warrants fur-
ther investigation. Coupled with our
recent ﬁnding that the expression of
INHBA (encoding the bA subunit of
activin A) and BDNF, but not that
of NTF4, is regulated by prostaglan-
din E2 (PGE2) in the human fetal
ovary (Bayne et al., 2009), it appears
that extensive cross-talk may exist
between the signaling pathways regu-
lating germ and somatic cell interac-
tions around the time that follicle for-
mation is initiated.
In summary, we have identiﬁed sig-
niﬁcant differences in the expression
of the genes encoding the TrkB ligands
NT4 and BDNF both within and
between the developing ovaries of
humans and mice, and these varia-
tions suggest that the relative levels of
TrkB ligands may be signiﬁcant in
determining their effects. Further-
more, we have demonstrated selective
transcriptional regulation by activin
of the genes encoding BDNF in the
human, and NT4 in the mouse, posi-
tioning these factors as potential so-
matic cell-derived components of a
regulatory pathway that controls
germ cell survival or maturation in
response to oocyte-derived activin,
and further expanding the repertoire
of growth factors regulated by this pro-
tein. The results presented here illus-
trate the complexity and interdepend-
ency of growth factor signaling
networks thatmediate communication
between the germ and somatic cell
compartments around the time of pri-
mordial follicle formation. They also
highlight the existence of major differ-
ences between humans and rodents in
seemingly conserved signaling path-
ways during ovarian development,
thus underlining the importance of
studying human ovarian physiology
directly rather than extrapolating
solely from rodent models. Further
elucidation of the factors regulating
the onset and extent of primordial fol-
licle formation, and their downstream
targets, may provide insight into the
pathogenesis of premature ovarian
failure, and inform strategies to pro-
mote oocyte differentiation from germ-
line stem cells in vitro for the study
and treatment of this condition.
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EXPERIMENTAL
PROCEDURES
Animals
Mice (C57Bl6J) were housed in an
environmentally controlled room on a
14-hr light, 10-hr dark photoperiod in
accordance with UK legal require-
ments. To obtain staged embryos,
females were housed with a proven
male overnight and inspected the fol-
lowing morning for vaginal plugs. Any
plugged females were determined to
be at E0.5, with the day of birth then
designated as P0.
Collection of Human
Fetal Tissues
Fetal ovaries were obtained from mor-
phologically normal human fetuses
(9–20 weeks gestational age) following
elective medical termination of preg-
nancy. Informed consent was obtained
and the study approved by the Lothian
University Hospitals ethics commit-
tee. Pregnancies were terminated by
treatment with mifepristone (200 mg
orally) followed 48 hr later by miso-
prostol (800 mg, 3 hourly per vagi-
num). Gestational age was estimated
by ultrasound scan before termina-
tion, and conﬁrmed by direct measure-
ment of foot length. Dissected ovaries
were ﬁxed in Bouins solution and proc-
essed into parafﬁn using standard
methods (for immunohistochemistry,
all gestations), frozen and stored at
80C (for RNA extraction, 14–20
weeks gestation), or prepared for use
in culture experiments as described
below.
RNA Isolation and cDNA
Synthesis
Total RNA was extracted from frozen
and cultured human fetal ovaries
using the RNeasyMini/Micro Kit (Qia-
gen, Crawley, UK) with on-column
DNaseI digestion as per the manufac-
turer’s instructions. Reverse tran-
scription was performed using Expand
Reverse Transcriptase (Roche Diag-
nostics, Lewes, UK) as described pre-
viously (Coutts et al., 2008). RNA from
cultured mouse ovarian somatic cells
was extracted using Qiashedders (Qia-
gen, Crawley, UK) with the RNeasy
Micro Kit and subsequently reverse
transcribed using a Quantitect Re-
verse Transcription Kit (Qiagen)
according to the manufacturer’s
instructions.
Quantitative RT-PCR
Analysis of TrkB ligand gene expres-
sion in human and mouse feto-neona-
tal ovaries was performed by qRT-PCR
using a Lightcycler 1.0 instrument
(Roche Diagnostics Ltd, Welwyn Gar-
den City, UK) and SYBR Green PCR
Master Mix (Qiagen), with melt curve
analysis as described previously
(Hartley et al., 2002; Coutts et al.,
2008). Increasing dilutions (from 1:5
to 1:10,000) of fetal human or mouse
ovary cDNA were used to generate
standard curves of the number of
cycles needed to yield a ﬂuorescent sig-
nal above background against the log
of relative concentration. The result-
ing slope of the curve is a measure of
the efﬁciency of the PCR reaction
(Hartley et al., 2002). The slopes of the
standard curves are indicative of the
efﬁciency of the PCR reaction and
were all close to 3.3 (equivalent to
100%PCR efﬁciency or two-fold ampli-
ﬁcation per cycle), allowing quantiﬁca-
tion using the 2DDCt method (Bayne
et al., 2009). What small differences
did exist were nevertheless taken into
account when calculating the relative
concentrations of each gene product,
and adjusted for the relativemolecular
weight of each amplicon to give molar
masses. Primer sequences and assays
used are detailed in Table 1. Calcula-
tion of human BDNF and NTF4
mRNA concentrations weremade rela-
tive to GAPDH to allow comparisons
between cDNAs. Bdnf and Ntf5 levels
were calculated relative to murine
Gapdh. Analysis of murine Ntf5
expression in response to activin treat-
ment was performed using SYBR
Green technology on an Opticon DNA
Engine (MJ Research,MA, USA).
Immunohistochemistry
Immunohistochemistry was per-
formed essentially as described previ-
ously (Martins da Silva et al., 2004)
with the following modiﬁcations.
After dewaxing, antigens were re-
trieved by pressure cooking in 0.01 M
sodium citrate buffer for 5 min. Sec-
tions were blocked for 30 min in nor-
mal swine serum diluted 1:5 in Tris
buffered saline (TBS; pH7.4) supple-
mented with 5% bovine serum albu-
min (BSA), followed by further blocks
using the streptavidin/biotin blocking
kit (Vector Labs, Peterborough, UK)
with TBS washes between each step.
Sections were incubated overnight at
4C in anti-BDNF (Santa Cruz
TABLE 1. qRT-PCR Primers and Primer Assays Used in This Studya
Protein Species Gene symbol Forward primer (50-30) Reverse primer (50-30)
BDNF Human BDNF AACAATAAGGACGCAGACTT TGCAGTCTTTTTGTCTGCCG
Mouse Bdnf AACCATAAGGACGCGGACTT TGCAGTCTTTTTATCTGCCG
NT4 Human NTF4 Quantitect Hs_NTF4_1_SG primer assayb
Mouse Ntf5 Quantitect Mm_Ntf5_1_SG primer assayb
GAPDH Human GAPDH GACATCAAGAAGGTGGTGAAGC GTCCACCACCCTGTTGCTGTAG
Mouse Gapdh GGGTGTGAACCACGAGAAAT CCTTCCACAATGCCAAAGTT
aqRT-PCR, quantitative reverse transcriptase-polymerase chain reaction; BDNF, brain-derived neurotrophic factor; NT4, neuro-
trophin-4; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
bObtained from QIAGEN (Crawley, UK).
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Biotech, Santa Cruz, CA) primary
antibody (diluted 1:50 in blocking so-
lution). The primary antibody was
detected using biotinylated-swine
anti-rabbit secondary antibody
(DAKO, Cambridge, UK) diluted
1:500 in blocking solution for 30 min
at room temperature, followed by a
further incubation of 30 min with
streptavidin-HRP (Vector Labs)
diluted 1:1,000 in TBS. Bound anti-
bodies were visualized using 3,30-dia-
minobenzidine tetrahydrochloride
(DAKO). Primary antibody preincu-
bated in the presence of excess immu-
nizing peptide (BDNF) was used as a
negative control. Slides were counter-
stained with hemotoxylin, dehydrated
and mounted, and photographed
using a Provis microscope (Olympus,
London, UK).
Effect of Activin Treatment
on Neurotrophin Expression
Human fetal ovaries (n ¼ 5; 14–17
weeks gestational age) were disaggre-
gated to a single cell suspension and
cultured in the presence or absence of
100 ng/ml recombinant human activin
A (R&D Systems, Abingdon, UK) for
18–24 hr exactly as described previ-
ously (Coutts et al., 2008). RNA extrac-
tion and cDNA synthesis were per-
formed as described previously
(Coutts et al., 2008), with determina-
tion of BDNF and NTF4 expression by
qRT-PCR performed as detailed above.
Ovaries were dissected from 8 P0
mice were placed into tubes contain-
ing 1 ml prewarmed Tryple Express
(Invitrogen, Paisley, UK) and warmed
at 37C for 20 min. Ovaries were then
pipetted vigorously until they had
completely disaggregated. One millili-
ter control medium (Waymouth’s me-
dium (Invitrogen) supplemented with
0.3%BSA and 10 IU/10 mg/ml penicil-
lin and streptomycin) was added and
the suspension centrifuged at 2,000 g
for 5 min. The cell pellet was resus-
pended in 100 ml of medium and dis-
tributed equally between 4 wells of a
24-well tissue culture plate, 2 wells
containing 1 ml of control medium
and 2 wells containing medium sup-
plemented with 100 ng/ml activin A
(R&D Systems). Cultures were main-
tained in a 5% CO2, 95% air incubator
at 37C. After 24 hr, a complete media
change was performed to remove any
remaining oocytes or cellular debris.
The cultures were then incubated for
a further 96 hr, with 500 ml medium
exchanged after 48 hr. Cells were
recovered by trypsinization using Try-
ple Express, followed by centrifuga-
tion for 15 min at 1,000 g and RNA
extracted and analyzed for changes in
Ntf5 and Bdnf expression as detailed
above.
Statistics
RT-PCR data on TrkB ligand expres-
sion over gestational ranges in the
human and mouse were analyzed by
analysis of variance with post hoc
Bonferroni tests. Paired t-tests were
used to determine signiﬁcance in
changes in TrkB ligand expression in
response to activin treatment.
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